Jingzhan Lu
A PhD student with a passion for Computational Genetics of Healthcare 🧬
Recent News
 [1]. European Society of Human Genetics 2025 (ESHG 2025 @Milan): Oral Presentaion @European conference fellowship
- 24 - 27 May - @ESHG Info
- Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS)
 [2]. Cancer in Primary Care Research International (Ca-PRI) Conference 2025: Oral Presentaion @Manchester
- In Coming Soon - @April 2025, Ca-PRI Info
- Combing the PSA test with Polygenic Risk Scores (PRS/GRS) to improve the prostate cancer diagnosis and prediction in primary care
 [3]. UK Biobank Scientific Conference 2024: Poster Presentaion @London
- Predicting prostate cancer by combining Prostate Specific Antigen (PSA) test results with Genetic Risk Scores (GRS) in the UK Biobank
 [4]. European Society of Human Genetics 2024 (ESHG 2024 @Berlin)：Poster Presentaion
- Impact of control selection strategies on GWAS results: a study of Schizophrenia and Bipolar Disorder in the UK Biobank
- P17.015.D - Poster Viewing Group D, Abstract available @ESHG Info
Click to Connect  @JingzhanLu
Education
- University of Exeter (Medical School)             10/2023 - Now
- PhD Genetics and Genomics
- Genetics of Complex Traits Research Group
- University College London (UCL)                 09/2021 - 12/2022
- MSc Health Data Science
- Human Genetics @UCL Lab
- Taiwan Tzu Chi University（College of Medicine）       09/2017 - 07/2021
- BEng Medical Informatics (Bioinfor Track)
Research
-
Predicting Prostate Cancer by combining prostate-specific antigen (PSA) test results with Genetic Risk Scores (GRS)
- Impact of control selection strategies on GWAS results – a study of the Schizophrenia and Bipolar Disorder in the UK Biobank
(Available on ResearchGate)
                                        Manhattan-Comparison Plot
- To develop a platform for the identification of Gram-stained images using Deep Convolutional Neutral Network
- Molecular docking analysis of Ritonavir, Lopinavir, Atazanavir, Darunavir and TMC-31091 as SARS-CoV-2 3CLpro inhibitors
         Â
Social Media
I can be found on the following creative platforms：
- ResearchGate：Jingzhan Lu
- LinkedIn：Jingzhan Lu
- Instagram：lujingzhan
Conference and Talk
- ESHG 2024, European Human Genetics Conference 2024, Berlin, Germany
- SGGD 2024, Genetics of Diabetes, University of Exeter, UK
- 2022 AI-DLDA Summer School, University of Udine, Italy：YouTube Video
Contact
- Email: 106316153@gms.tcu.edu.tw